In This Issue
Screening High-Risk Populations for Lung Cancer
Nationwide Quality Improvement in Lung Cancer Care
Stage-Adjusted Lung Cancer Survival Does Not Differ between Low-Income Blacks and Whites
Associations between TS, TTF-1, FR-α, FPGS, and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Pemetrexed Plus Carboplatin or Gemcitabine Plus Carboplatin as First-Line Chemotherapy
Small-Cell Carcinoma in the Setting of Pulmonary Adenocarcinoma
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer
Outcome and Prognostic Factors in Bronchial Carcinoids
Identification of Early T1b Lung Adenocarcinoma Based on Thin-Section Computed Tomography Findings
Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients
Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer
ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma
Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma
NUT Midline Carcinoma
An Unusual Cause of Dysphagia in a 76-Year-Old Heavy Smoker
Surgical Treatment of a Giant Symptomatic Cardiac Lipoma
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
Asbcopal Effects after Conventional and Stereotactic Lung Irradiation of Non-Small-Cell Lung Cancer
Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non-Small-Cell Lung Cancer
Acute Autoimmune Hepatitis, Myositis, and Myasthenic Crisis in a Patient with Thymoma
A Case of Pleural Epithelioid Sarcoma of Proximal Type Presenting as Malignant Pleural Mesothelioma
A New KIT Gene Mutation in Thymic Cancer and a Promising Response to Imatinib